Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2003

01-05-2003 | Letter to the Editor

Rat-Bite Fever? A Reply to Clement et al.

Authors: D. Schultze, Å. Lundkvist, P. Heyman

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2003

Login to get access

Excerpt

In our recent case report [1] we presented the first documented case of acute human infection with Tula virus (TULV). In a letter to the editor, Clement et al. [2] have regarded the serological data as compatible with a recent infection by TULV but rejected its pathogenicity for the patient. Furthermore, they argue that all of the clinical symptoms could be attributed to an infection by Streptobacillus moniliformis, one of the causative agents of rat-bite fever (RBF). Following are our reasons why we remain convinced about the pathogenicity of TULV for humans and why we discard RBF as a diagnosis. …
Literature
1.
go back to reference Schultze D, Lundkvist Å, Blauenstein U, Heyman P (2002) Tula virus infection associated with fever and exanthema after a wild rodent bite. Eur J Clin Microbiol Infect Dis 21:304–306CrossRefPubMed Schultze D, Lundkvist Å, Blauenstein U, Heyman P (2002) Tula virus infection associated with fever and exanthema after a wild rodent bite. Eur J Clin Microbiol Infect Dis 21:304–306CrossRefPubMed
2.
go back to reference Clement J, Frans J, Van Ranst M (2003) Human Tula virus infection or rat-bite fever? Eur J Clin Microbiol Infect Dis DOI 10.1007/s10096-003-0921-7 Clement J, Frans J, Van Ranst M (2003) Human Tula virus infection or rat-bite fever? Eur J Clin Microbiol Infect Dis DOI 10.1007/s10096-003-0921-7
3.
go back to reference McCaughey C, Hart CA (2000) Hantaviruses. J Med Microbiol 49:587–599PubMed McCaughey C, Hart CA (2000) Hantaviruses. J Med Microbiol 49:587–599PubMed
4.
go back to reference Mertz GJ, Hjelle BRL, Bryan RT (1997) Hantavirus infection. Adv Intern Med 42:369–421PubMed Mertz GJ, Hjelle BRL, Bryan RT (1997) Hantavirus infection. Adv Intern Med 42:369–421PubMed
5.
go back to reference Mustonen J, Huttunen N-P, Brummer-Korvenkontio M, Vaheri A (1994) Clinical picture of nephropathia epidemica in children. Acta Paediatr 83:526–529PubMed Mustonen J, Huttunen N-P, Brummer-Korvenkontio M, Vaheri A (1994) Clinical picture of nephropathia epidemica in children. Acta Paediatr 83:526–529PubMed
6.
go back to reference Linderholm M, Elgh F (2001) Clinical characteristics of hantavirus infections on the Eurasian continent. Curr Top Microbiol Immunol 256:135–151PubMed Linderholm M, Elgh F (2001) Clinical characteristics of hantavirus infections on the Eurasian continent. Curr Top Microbiol Immunol 256:135–151PubMed
7.
go back to reference Graves MH, Janda JM (2001) Rat-bite fever (Streptobacillus moniliformis): a potential emerging disease. Int J Infect Dis 5:151–155PubMed Graves MH, Janda JM (2001) Rat-bite fever (Streptobacillus moniliformis): a potential emerging disease. Int J Infect Dis 5:151–155PubMed
8.
go back to reference Raffin BJ, Freemark M (1979) Streptobacillary rat-bite fever: a pediatric problem. Pediatrics 64:214–217PubMed Raffin BJ, Freemark M (1979) Streptobacillary rat-bite fever: a pediatric problem. Pediatrics 64:214–217PubMed
9.
go back to reference Ojukwu IC, Christy C (2002) Rat-bite fever in children: case report and review. Scand J Infect Dis 34:477CrossRefPubMed Ojukwu IC, Christy C (2002) Rat-bite fever in children: case report and review. Scand J Infect Dis 34:477CrossRefPubMed
10.
go back to reference Frans J, Verhaegen J, Van Noyen R (2001) Streptobacillus moniliformis: case report and review of the literature. Acta Clin Belg 56:187–190PubMed Frans J, Verhaegen J, Van Noyen R (2001) Streptobacillus moniliformis: case report and review of the literature. Acta Clin Belg 56:187–190PubMed
11.
go back to reference Hagelskjaer L, Sørensen I, Randers E (1998) Streptobacillus moniliformis infection: 2 cases and a literature review. Scand J Infect Dis 30:309–311CrossRefPubMed Hagelskjaer L, Sørensen I, Randers E (1998) Streptobacillus moniliformis infection: 2 cases and a literature review. Scand J Infect Dis 30:309–311CrossRefPubMed
12.
go back to reference Schlossberg D, Shulman JA, Shader RI (1996) Differential diagnosis of infectious diseases. Williams & Wilkins, Baltimore, pp 1–339 Schlossberg D, Shulman JA, Shader RI (1996) Differential diagnosis of infectious diseases. Williams & Wilkins, Baltimore, pp 1–339
13.
go back to reference Cunningham BB, Paller AS, Katz BZ (1998) Rat bite fever in a pet lover. J Am Acad Dermatol 38:330–332PubMed Cunningham BB, Paller AS, Katz BZ (1998) Rat bite fever in a pet lover. J Am Acad Dermatol 38:330–332PubMed
14.
go back to reference Goldstein EJC (1992) Bite wounds and infection. Clin Infect Dis 14:633–640PubMed Goldstein EJC (1992) Bite wounds and infection. Clin Infect Dis 14:633–640PubMed
15.
go back to reference Faulde M, Hoffmann G (2001) Human vector-borne diseases in Germany—presence of vector transmissible agents, preventive and zoonotic aspects. Bundesgesundheitsblatt—Gesundheitsforschung—Gesundheitsschutz 44:116–136 Faulde M, Hoffmann G (2001) Human vector-borne diseases in Germany—presence of vector transmissible agents, preventive and zoonotic aspects. Bundesgesundheitsblatt—Gesundheitsforschung—Gesundheitsschutz 44:116–136
16.
go back to reference Glastonbury JR, Morton JG, Matthews LM (1996) Streptobacillus moniliformis infection in Swiss white mice. J Vet Diagn Invest 8:202–209PubMed Glastonbury JR, Morton JG, Matthews LM (1996) Streptobacillus moniliformis infection in Swiss white mice. J Vet Diagn Invest 8:202–209PubMed
17.
go back to reference Lundkvist Å, Vapalahti O, Plyusnin A, Sjölander KB, Niklasson B, Vaheri A (1996) Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein. Virus Res 45:29–44CrossRefPubMed Lundkvist Å, Vapalahti O, Plyusnin A, Sjölander KB, Niklasson B, Vaheri A (1996) Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein. Virus Res 45:29–44CrossRefPubMed
18.
go back to reference Lundkvist Å, Hukic M, Hörling J, Gilljam M, Nichol St, Niklasson B (1997) Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J Med Virol 53:51–59CrossRefPubMed Lundkvist Å, Hukic M, Hörling J, Gilljam M, Nichol St, Niklasson B (1997) Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J Med Virol 53:51–59CrossRefPubMed
19.
go back to reference Lundkvist Å, Vapalahti O, Henttonen H, Vaheri A, Plyusnin A (2000) Hantavirus infections among mammalogists studied by focus reduction neutralisation test. Eur J Clin Microbiol Infect Dis 19:802–803CrossRefPubMed Lundkvist Å, Vapalahti O, Henttonen H, Vaheri A, Plyusnin A (2000) Hantavirus infections among mammalogists studied by focus reduction neutralisation test. Eur J Clin Microbiol Infect Dis 19:802–803CrossRefPubMed
20.
go back to reference Doyle AC (1926) The adventure of the blanched soldier. In: The Case-Book of Sherlock Holmes. Liberty Doyle AC (1926) The adventure of the blanched soldier. In: The Case-Book of Sherlock Holmes. Liberty
Metadata
Title
Rat-Bite Fever? A Reply to Clement et al.
Authors
D. Schultze
Å. Lundkvist
P. Heyman
Publication date
01-05-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-0922-6

Other articles of this Issue 5/2003

European Journal of Clinical Microbiology & Infectious Diseases 5/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine